Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Apr 2512:30 AM EDT
-01:30 AM EDT
At one point, she believed GMAT wasn’t for her. After scoring 595, self-doubt crept in and she questioned her potential. But instead of quitting, she made the right strategic changes. The result? A remarkable comeback to 695. Check out how Saakshi did it.
Apr 2601:30 AM EDT
-02:30 AM EDT
Learn how Keshav, a Chartered Accountant, scored an impressive 705 on GMAT in just 30 days with GMATWhiz's expert guidance. In this video, he shares preparation tips and strategies that worked for him, including the mock, time management, and more.
Apr 2610:00 AM EDT
-11:00 AM EDT
The Target Test Prep course represents a quantum leap forward in GMAT preparation, a radical reinterpretation of the way that students should study. Try before you buy with a 5-day, full-access trial of the course for FREE!
Apr 2711:00 AM EDT
-12:00 PM EDT
Prefer video-based learning? The Target Test Prep OnDemand course is a one-of-a-kind video masterclass featuring 400 hours of lecture-style teaching by Scott Woodbury-Stewart, founder of Target Test Prep and one of the most accomplished GMAT instructors
Apr 2808:00 AM PDT
-11:00 AM PDT
Whether you are just beginning your MBA journey or fine-tuning your path to a 700+ score, GMAT Day is designed to give you a competitive edge.
May 0111:00 AM PDT
-12:00 PM PDT
Free- full-length test + 15 concept videos + 150+ short videos + study plan!
24 Aug 2024, 06:12
Kudos
Bookmarks
E
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
5%
(low)
Question Stats:
91% (01:30) correct
9%
(01:39)
wrong
based on 188
sessions
History
Date
Time
Result
Not Attempted Yet
Clinician: Patients with immune system disorders are usually treated with a class of drugs that, unfortunately, increase the patient's risk of developing osteoporosis, a bone-loss disease. So these patients take another drug that helps to preserve existing bone. Since a drug that enhances the growth of new bone cells has now become available, these patients should take this new drug in addition to the drug that helps to preserve existing bone.
Which one of the following would be most useful to know in order to evaluate the clinician's argument?
(A) How large is the class of drugs that increase the risk of developing osteoporosis?
(B) Why are immune system disorders treated with drugs that increase the risk of developing osteoporosis?
(C) Is the new drug more expensive than the drug that helps to preserve existing bone?
(D) How long has the drug that helps to preserve existing bone been in use?
(E) To what extent does the new drug retain its efficacy when used in combination with the other drugs?
Which one of the following would be most useful to know in order to evaluate the clinician's argument?
(A) How large is the class of drugs that increase the risk of developing osteoporosis?
(B) Why are immune system disorders treated with drugs that increase the risk of developing osteoporosis?
(C) Is the new drug more expensive than the drug that helps to preserve existing bone?
(D) How long has the drug that helps to preserve existing bone been in use?
(E) To what extent does the new drug retain its efficacy when used in combination with the other drugs?
RishS94
Joined: 05 Jan 2020
Last visit: 27 Feb 2025
Posts: 266
Own Kudos:
Given Kudos: 118
Location: India
Concentration: Strategy, Sustainability
Schools: ISB '25 (D)
GMAT 1: 690 Q49 V35
GPA: 3.5
Products:
25 Aug 2024, 05:32
Kudos
Bookmarks
Drug X will stop OP.
Drug Y will aid bone growth.
So take X + Y.
Assumption X+Y won't interfere to reduce the loss.
Drug Y will aid bone growth.
So take X + Y.
Assumption X+Y won't interfere to reduce the loss.
25 Aug 2024, 20:50
Kudos
Bookmarks
Conclusion: Patients with immune system disorders should take the new drug that enhances the growth of new bone cells in addition to the existing drug that helps to preserve existing bone
Which one of the following would be most useful to know in order to evaluate the clinician's argument?
(A) How large is the class of drugs that increase the risk of developing osteoporosis?
NO. This might help in evaluating the existing drug usage, this wont help in Clinician's argument on taking the new drug.
(B) Why are immune system disorders treated with drugs that increase the risk of developing osteoporosis?
NO. This might be a unfortunate side effect of class of drugs for immune system disorders. This will not help in evaluating why the patients should take both new and existing drug for osteoporosis.
(C) Is the new drug more expensive than the drug that helps to preserve existing bone?
NO. Cost of the drugs has no bearing in a suggestion for drugs. Irrelevant.
(D) How long has the drug that helps to preserve existing bone been in use?
NO. It may be a new drug developed few months ago or being used for years. This doesnt help in finding why the new drug should be taken in addition.
(E) To what extent does the new drug retain its efficacy when used in combination with the other drugs?
YES. If the efficacy of the new drug drops down when it is combined with a drug that helps to preserve bone, then Clinician's argument or recommendation becomes weak.
Answer is E
Which one of the following would be most useful to know in order to evaluate the clinician's argument?
(A) How large is the class of drugs that increase the risk of developing osteoporosis?
NO. This might help in evaluating the existing drug usage, this wont help in Clinician's argument on taking the new drug.
(B) Why are immune system disorders treated with drugs that increase the risk of developing osteoporosis?
NO. This might be a unfortunate side effect of class of drugs for immune system disorders. This will not help in evaluating why the patients should take both new and existing drug for osteoporosis.
(C) Is the new drug more expensive than the drug that helps to preserve existing bone?
NO. Cost of the drugs has no bearing in a suggestion for drugs. Irrelevant.
(D) How long has the drug that helps to preserve existing bone been in use?
NO. It may be a new drug developed few months ago or being used for years. This doesnt help in finding why the new drug should be taken in addition.
(E) To what extent does the new drug retain its efficacy when used in combination with the other drugs?
YES. If the efficacy of the new drug drops down when it is combined with a drug that helps to preserve bone, then Clinician's argument or recommendation becomes weak.
Answer is E
